VYGR
VYGR
NASDAQ · Biotechnology

Voyager Therapeutics Inc

$1.76
-0.07 (-3.56%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +2,538.6% upside
Low Target $29.94
Average Target $46.44
High Target $64.67
Current Price $1.76
Current
$1.76
Target
$46.44
$29.94 $46.44 avg $64.67
Scenario Analysis
Bear Case
$29.94
1,601.1%
Low target
Base Case
$46.44
+2,538.6%
Avg target
Bull Case
$64.67
+3,574.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.48
-67.9% from high
52-Week Low
$1.68
+5.1% from low
Target vs 52W High
$46.44
+747.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%